Gastroesophageal reflux disease (GERD) is associated with more severe interstitial lung disease (ILD) in systemic sclerosis (SSc), according to study findings published in Rheumatology.

Receiving admilparant, an oral lysophosphatidic acid receptor 1 antagonist, for 26 weeks lowered percent-predicted FVC ...

The following is a summary of "Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: ...

With symptoms that often mimic other respiratory conditions, ILD is frequently misdiagnosed or unrecognized. However, in the ...

Coreline Soft will demonstrate its cutting-edge AI-based lung and thoracic imaging solution lineup at the Society of Thoracic Radiology 2025 (STR) on March 1st. STR is an international academic event ...

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its new drug application for zongertinib (BI 1810631) for the treatment of adult ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

Children diagnosed with interstitial lung disease (ILD) are now more likely to survive into adulthood and may thus need care from adult ILD clinics for related impairments and complications. These ...

Objectives Anti-Ro52 autoantibodies are associated with more severe interstitial lung disease (ILD ... Furthermore, patients with anti-Ro52 autoantibodies have more severe disease and a poorer ...

Background Patients with interstitial lung disease (ILD) are at risk of developing nocturnal ... associations, management and prognosis of nocturnal hypoxaemia in ILD. Methods Ovid MEDLINE, Embase and ...

1 Among them, anti-MDA5 presented with a a greater risk with interstitial lung disease (ILD), which may lead to poor prognosis. In clinical practice, some patients are refractory to immunosuppressive ...